Home > PS Ratio > ONESOURCE SPECIALTY PHARMA

ONESOURCE SPECIALTY PHARMA
PS (Price/Sales) Ratio

The Current P/S Ratio of ONESOURCE SPECIALTY PHARMA is 11.40.

Share Price ₹1,534.4Aug 18,2026
Market Cap ₹17,599.0 Cr
Sales-TTM₹1,543.3 CrTTM-Consolidated Results
Price/Sales11.40xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for ONESOURCE SPECIALTY PHARMA
Please provide your vote to see the results
ONESOURCE SPECIALTY PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of ONESOURCE SPECIALTY PHARMA

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of ONESOURCE SPECIALTY PHARMA is calculated as :

Current Market Cap [ ₹17,599.0 Cr] as on Aug 18,2026

(/) Sales [ ₹1,543.3 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 11.40x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for ONESOURCE SPECIALTY PHARMA , the investors are currently willing to pay '11.40 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of ONESOURCE SPECIALTY PHARMA !

The chart below summarizes the trend in P/S Ratio of ONESOURCE SPECIALTY PHARMA over the last five years.

Historical PS (Price/Sales) ratio chart of ONESOURCE SPECIALTY PHARMA


PS Ratio Performance Analysis for ONESOURCE SPECIALTY PHARMA

- ONESOURCE SPECIALTY PHARMA 's latest p/e ratio is 11.40x.

- ONESOURCE SPECIALTY PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2022 averaged 3.46x.

- ONESOURCE SPECIALTY PHARMA 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 4 fiscal years, ONESOURCE SPECIALTY PHARMA 's p/e ratio peaked in Mar2025 at 13.84x.

- ONESOURCE SPECIALTY PHARMA 's p/e ratio hit its five-year low in Mar2024 of 0x.


How does ONESOURCE SPECIALTY PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
ONESOURCE SPECIALTY PHARMA 1,543.311.4017,599.0
SUN PHARMACEUTICAL INDUSTRIES LTD59,910.57.51450,211.0
DIVIS LABORATORIES LTD11,230.020.33228,303.0
TORRENT PHARMACEUTICALS LTD15,723.012.04189,233.0
CIPLA LTD28,324.44.08115,672.0
DR REDDYS LABORATORIES LTD33,227.92.9798,533.5
MANKIND PHARMA LTD14,737.96.7098,706.0
LUPIN LTD29,966.63.39101,735.0
ZYDUS LIFESCIENCES LTD28,591.73.90111,421.0
AUROBINDO PHARMA LTD34,935.32.7094,272.8
LAURUS LABS LTD7,269.613.4998,034.2

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ONESOURCE SPECIALTY PHARMA 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.70x
Max industry PS 20.33x
Median industry PS 6.70x
Average industry PS 8.05x



You may also like the below Video Courses